Our people
Chief Executive Officer
Chief Scientific Officer
Prof. Osterhaus has led numerous scientific projects on virus intervention strategies and authored over 1,350 scientific papers with a citation index exceeding 140.
Head Clinical Strategy
A passionate, empathic and energetic leader with extensive experience in evidence strategy & clinical development for pharma, medical devices and nutrition. Dedicated to connecting biology, investigational products, regulation, and business into one coherent development path that maximizes the chance a product reaches patients.
Head Clinical Operations
Motivational team player and operations lead with a global track record in clinical development, covering a wide range of therapeutic domains. Extensive experience in early stage product development for pharma and biotech companies.
Director Clinical Strategy & BD
Dynamic life-science business development leader with over 20 years across biotech, medical devices, and CRO services, combining deep clinical operations expertise with senior and global project leadership. Passionate about divergent thinking and bringing purpose to science.
Clinical Strategy Manager & BD
Oskar Szelest is a biophysicist and life sciences business development professional working with pharmaceutical and biotech companies on early clinical development strategies. He combines scientific expertise with industry insight to support translational programs and partnerships that advance innovative therapies toward clinical validation.